Ex-InterMune CEO Says Withheld Docs Clear His Name
A former InterMune Inc. CEO convicted of fraudulently marketing one of his company's drugs for a deadly lung disease is fighting for a new trial, saying the U.S. government unlawfully delayed...To view the full article, register now.
Already a subscriber? Click here to view full article